Literature DB >> 15312684

2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro.

Agnieszka Lis1, Michael J Ciesielski, Tara A Barone, Bryan E Scott, Robert A Fenstermaker, Robert J Plunkett.   

Abstract

2-Methoxyestradiol (2ME), a metabolite of estradiol (E), inhibits proliferation of various tumor cells. In this study we determined the effect of 2ME on human glioblastoma cell lines, in vitro. We compared these cells with cultured astrocytes obtained from traumatized adult rat striatum. Exposure to 2ME had a strong antiproliferative effect on human glioblastoma and caused an increase in the population of apoptotic cells, detected by flow cytometry, in some of the investigated cell lines. A significant number of cells were blocked in the G2/M phase of the cell cycle. Concurrently, the population of cells in the G1 phase decreased in all glioblastoma cell lines. Staining with Hoechst 33258 revealed abnormal nuclear morphology in the proliferating cells treated with 2ME. Treatment with 2ME induced upregulation of wild type p53 in one of the human glioblastoma cell lines as well as in proliferating adult rat astrocytes. We conclude that 2ME inhibits the growth of human glioblastoma cell lines and induces apoptosis, in vitro. This compound deserves further investigation as a treatment for gliomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312684     DOI: 10.1016/j.canlet.2004.04.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study.

Authors:  Geoffrey C Kabat; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin; Thomas E Rohan
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

2.  Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies.

Authors:  Yu-Long Lan; Xun Wang; Jia-Cheng Lou; Bin-Bin Ma; Jin-Shan Xing; Shuang Zou; Bo Zhang
Journal:  J Neurooncol       Date:  2017-12-26       Impact factor: 4.130

3.  Reproductive factors in relation to risk of brain tumors in women: an updated meta-analysis of 27 independent studies.

Authors:  Hailiang Zong; Hongsheng Xu; Zhongqun Geng; Chong Ma; Xing Ming; Ming Shang; Kai Li; Xiaoguang He; Hai Du; Jianping Zhao; Lei Cao
Journal:  Tumour Biol       Date:  2014-08-19

4.  Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.

Authors:  Dominique S Michaud; Valentina Gallo; Brigitte Schlehofer; Anne Tjønneland; Anja Olsen; Kim Overvad; Christina C Dahm; Rudolf Kaaks; Annekatrin Lukanova; Heiner Boeing; Madlen Schütze; Antonia Trichopoulou; Christina Bamia; Andreas Kyrozis; Carlotta Sacerdote; Claudia Agnoli; Domenico Palli; Rosario Tumino; Amalia Mattiello; H Bas Bueno-de-Mesquita; Martine M Ros; Petra H M Peeters; Carla H van Gils; Eiliv Lund; Kjersti Bakken; Inger T Gram; Aurelio Barricarte; Carmen Navarro; Miren Dorronsoro; Maria José Sánchez; Laudina Rodríguez; Eric J Duell; Göran Hallmans; Beatrice S Melin; Jonas Manjer; Signe Borgquist; Kay-Tee Khaw; Nick Wareham; Naomi E Allen; Konstantinos K Tsilidis; Isabelle Romieu; Sabina Rinaldi; Paolo Vineis; Elio Riboli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-27       Impact factor: 4.254

Review 5.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

6.  Reproductive factors and hormone use and risk of adult gliomas.

Authors:  Martha J Felini; Andrew F Olshan; Jane C Schroeder; Susan E Carozza; Rei Miike; Terri Rice; Margaret Wrensch
Journal:  Cancer Causes Control       Date:  2008-09-03       Impact factor: 2.506

7.  PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression.

Authors:  Carrie R Muh; Shweta Joshi; Alok R Singh; Santosh Kesari; Donald L Durden; Milan T Makale
Journal:  J Neurooncol       Date:  2013-10-27       Impact factor: 4.130

8.  Estrogen increases survival in an orthotopic model of glioblastoma.

Authors:  Tara A Barone; Justin W Gorski; Steven J Greenberg; Robert J Plunkett
Journal:  J Neurooncol       Date:  2009-05-05       Impact factor: 4.130

9.  Reproductive factors and risk of primary brain tumors in women.

Authors:  Gabriella M Anic; Melissa H Madden; L Burton Nabors; Jeffrey J Olson; Renato V LaRocca; Zachary J Thompson; Shitaldas J Pamnani; Peter A Forsyth; Reid C Thompson; Kathleen M Egan
Journal:  J Neurooncol       Date:  2014-04-04       Impact factor: 4.130

10.  Parity, age at first birth, and risk of death from brain cancer: a population-based cohort study in Taiwan.

Authors:  Hui-Fen Chiu; Chih-Cheng Chen; Shang-Shyue Tsai; Shu-Chen Ho; Chun-Yuh Yang
Journal:  BMC Public Health       Date:  2012-10-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.